Terms: = Gastric cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Prognosis
57 results:
1. Vitamin D receptor gene variations and their haplotypic association: Possible impact on gastric cancer risk.
Qadir J; Majid S; Khan MS; Wani MD; Naikoo NA
J Cancer Res Ther; 2023; 19(5):1115-1125. PubMed ID: 37787272
[TBL] [Abstract] [Full Text] [Related]
2. Association of cdx2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancer.
Gao X; Han W; Chen L; Li H; Zhou F; Bai B; Yan J; Guo Y; Liu K; Li W; Li R; Yuan Q; Zhang J; Lu Y; Zhao X; Ji G; Li M; Zhao Q; Wu K; Li Z; Nie Y
Cancer Med; 2023 Sep; 12(17):17613-17631. PubMed ID: 37602699
[TBL] [Abstract] [Full Text] [Related]
3. Further prognostic stratification of intestinal type of gastric adenocarcinoma by cdx2 expression pattern.
Hao Y; Liu BL; Liang Y; Xiong Y; Polydorides AD; Ward S
Hum Pathol; 2023 Jan; 131():61-67. PubMed ID: 36403867
[TBL] [Abstract] [Full Text] [Related]
4. cdx2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal cancer.
Wang YS; Kou Y; Zhu RT; Han BW; Li CH; Wang HJ; Wu HB; Xia TM; Che XM
Dis Markers; 2022; 2022():9025668. PubMed ID: 36277982
[TBL] [Abstract] [Full Text] [Related]
5. TTN-AS1 delivered by gastric cancer cell-derived exosome induces gastric cancer progression through in vivo and in vitro studies.
Wang Y; Jiang R; Zhao H; Li F; Li Y; Zhu M
Cell Biol Toxicol; 2023 Apr; 39(2):557-571. PubMed ID: 36214926
[TBL] [Abstract] [Full Text] [Related]
6. Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study.
Arpa G; Fassan M; Guerini C; Quaquarini E; Grillo F; Angerilli V; Guzzardo V; Lonardi S; Bergamo F; Lenti MV; Pedrazzoli P; Paulli M; Di Sabatino A; Vanoli A
Virchows Arch; 2022 Dec; 481(6):853-863. PubMed ID: 35925388
[TBL] [Abstract] [Full Text] [Related]
7. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract] [Full Text] [Related]
8. Screening key genes and biomarkers in gastrointestinal metaplasia that progress to gastric cancer by integrated bioinformatics analysis.
Pang L; Yan X; Su D
J Physiol Pharmacol; 2021 Dec; 72(6):. PubMed ID: 35485356
[TBL] [Abstract] [Full Text] [Related]
9. CDX-1/CDX-2 Expression Is a Favorable Prognostic Factor in Epstein-Barr Virus-Negative, Mismatch Repair-Proficient Advanced gastric cancers.
Kim K; Noh S; Cheong JH; Kim H
Gut Liver; 2021 Sep; 15(5):694-704. PubMed ID: 34312322
[TBL] [Abstract] [Full Text] [Related]
10. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in gastric cancer.
Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B
Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168
[TBL] [Abstract] [Full Text] [Related]
11. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
[TBL] [Abstract] [Full Text] [Related]
12. gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection.
Li C; Wu X; Yang S; Yang X; Yao J; Zheng H
Diagn Pathol; 2020 Oct; 15(1):131. PubMed ID: 33097069
[TBL] [Abstract] [Full Text] [Related]
13. [gastric adenocarcinoma with enteroblastic differentiation and elevated serum alpha fetoprotein].
Li QZ; Zhao HB; Ban N; Wang Q; Zhang JJ; Ding SN; Li HH; Zhou ZH
Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):886-890. PubMed ID: 32892552
[No Abstract] [Full Text] [Related]
14. Clinical, histopathological and immunohistochemical features of brain metastases originating in colorectal cancer: a series of 27 consecutive cases.
Scripcariu V; Ciobanu Apostol DG; Dumitrescu GF; Turliuc MD; Sava A
Rom J Morphol Embryol; 2020; 61(1):81-93. PubMed ID: 32747898
[TBL] [Abstract] [Full Text] [Related]
15. A panel of intestinal differentiation markers (cdx2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis.
Lopes N; Bergsland C; Bruun J; Bjørnslett M; Vieira AF; Mesquita P; Pinto R; Gomes R; Cavadas B; Bennett E; Pereira L; Lothe RA; Almeida R; David L
Gastric Cancer; 2020 Sep; 23(5):811-823. PubMed ID: 32215766
[TBL] [Abstract] [Full Text] [Related]
16. High-level FGFR2 amplification is associated with poor prognosis and Lower response to chemotherapy in gastric cancers.
Hur JY; Chao J; Kim K; Kim ST; Kim KM; Klempner SJ; Lee J
Pathol Res Pract; 2020 Apr; 216(4):152878. PubMed ID: 32089408
[TBL] [Abstract] [Full Text] [Related]
17. gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum.
Kwon MJ; Byeon S; Kang SY; Kim KM
Pathol Res Pract; 2019 Sep; 215(9):152525. PubMed ID: 31301878
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic influence of cdx2 expression in gastric carcinoma after surgery with a curative intent.
Estrada Muñoz L; García Gómez de Las Heras S; Díaz Del Arco C; Cerón Nieto MA; Chicharro Uriguen J; Fernández Aceñero MJ
Rev Esp Enferm Dig; 2019 Jul; 111(7):514-518. PubMed ID: 31140285
[TBL] [Abstract] [Full Text] [Related]
19. Esophageal dysplasia and adenocarcinoma: a study with double immunostaining for intestinal and gastric markers.
Chlumská A; Mukenšnabl P; Waloschek T; Zámečník M
Cesk Patol; 2018; 54(2):81-85. PubMed ID: 30441967
[TBL] [Abstract] [Full Text] [Related]
20. TLR2 activation induced by H. pylori LPS promotes the differential expression of claudin-4, -6, -7 and -9 via either STAT3 and ERK1/2 in AGS cells.
Chavarría-Velázquez CO; Torres-Martínez AC; Montaño LF; Rendón-Huerta EP
Immunobiology; 2018 Jan; 223(1):38-48. PubMed ID: 29031421
[TBL] [Abstract] [Full Text] [Related]
[Next]
